But Axovant said it will continue to develop nelotanserin to treat hallucinations in patients with Parkinson’s disease dementia, and is planning a larger study that could lead to FDA approval.

CHICAGO (AP) — CHICAGO (AP) — Exelon Corp. (EXC) on Wednesday reported fourth-quarter earnings of $647 million. On a per-share basis, the Chicago-based company said it had profit of 64 cents.

Exelon Corporation EXC is scheduled to release fourth-quarter 2024 results on Feb. 12, before market open. The company delivered an earnings surprise of 5.97% in the last reported quarter. Exelon ...

Hello, and welcome to Exelon's Fourth Quarter Earnings Call. My name is Michelle, and I will be your event specialist today. [Operator Instructions] Please note that today's webcast is being recorded.

(Reuters) -Major U.S. electric utility Exelon increased its four-year capital investment plan by 10% to $38 billion, with the bulk of the spending aimed at bolstering and building new transmission ...

Four Exelon companies have earned placement among ... data analytics and advisory firm specializing in human and market behavior. The study evaluates utility companies’ ability to deliver ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, published Wednesday by JAMA Psychiatry, looked into 48 people the medi ...

The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. Experts say it’s not yet clear how safe these drugs are for people who don’t need to ...

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...